Vaccitech, Oxford University tie up with AstraZeneca for COVID-19 vaccine
COVID19 | News | 0 Comment | 01 May, 2020
Vaccitech Ltd and the University of Oxford have announce an agreement with the UK-based global biopharmaceutical company...Read more
CEPI invests $3.5M in Clover Australia for COVID-19 vaccine
COVID19 | News | 0 Comment | 01 May, 2020
Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...Read more
Biolidics launches rapid test kit for COVID-19
COVID19 | News | 2 Comment | 01 May, 2020
A rapid test kit for COVID-19 launched by former National University of Singapore (NUS) startup company, medtech firm Bi...Read more
360biolabs supports first Australian COVID-19 vaccine trial
COVID19 | News | By Ankit Kankar | 0 Comment | 30 Apr, 2020
In one of the first COVID-19 clinical vaccine trials, US-based clinical-stage biotechnology company Novavax has selected...Read more
Japan observes cross protection from COVID-19 by JEV
COVID19 | News | 0 Comment | 30 Apr, 2020
A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection ...Read more
HKBU unveils COVID-19 transmission patterns
COVID19 | News | 0 Comment | 29 Apr, 2020
New research led by Hong Kong Baptist University (HKBU) computer scientists has used a data-driven modelling a...Read more
Seasun Biomaterials set to launch COVID-19 rapid kit
COVID19 | News | 0 Comment | 29 Apr, 2020
South Korea based SEASUN BIOMATERIALS has announced that they are about to release their second COVID-19 assay "AQ-TOP C...Read more
Vela Diagnostics Receives BARDA Funding to Develop COVID-19 Tests
COVID19 | News | 0 Comment | 29 Apr, 2020
Vela Diagnostics has been awarded a $225,000 contract by the Biomedical Advanced Research and Development Authority (BAR...Read more
Vela Diagnostics receives CE mark for COVID-19 test
COVID19 | News | 0 Comment | 30 Apr, 2020
Singapore headquartered Vela Diagnostics announced that the manual version of the ViroKey™ SARS-CoV-2 RT-PCR Test ...Read more
Singapore develops comprehensive medical strategy for COVID-19
COVID19 | News | 0 Comment | 29 Apr, 2020
The Multi-Ministry Taskforce in Singapore has a comprehensive medical strategy to ensure that individuals infected with ...Read more
NanoPass joins pharma partners for COVID-19 vaccine development
COVID19 | News | 0 Comment | 27 Apr, 2020
Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...Read more
COVID19 | News | By Ankit Kankar | Covid19 Special Analytical Reporting | 0 Comment | 27 Apr, 2020
Countries are reporting testing data in different ways: some report the number of tests, others report the number of peo...Read more
Australia boosts COVID-19 response with additional $3M
COVID19 | News | 0 Comment | 28 Apr, 2020
The Australian Government will provide a further $3 million to support frontline health workers with training and inform...Read more
MiRXES to distribute A*STAR's SARS-CoV-2 RT-PCR test
COVID19 | News | 0 Comment | 28 Apr, 2020
MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Author...Read more
Terumo donates $2.4 M for COVID-19 fight
COVID19 | News | 0 Comment | 28 Apr, 2020
As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...Read more
Singapore designs AI platform to combat infectious diseases
COVID19 | News | 0 Comment | 27 Apr, 2020
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective trea...Read more
Scientists identify key nasal cells believed to attract Coronavirus
COVID19 | News | 0 Comment | 24 Apr, 2020
Two specific nose cell types have been identified as likely initial infection points for COVID-19 coronavirus. Scientist...Read more
CanSino Bio enrols for Ph 2 trial of COVID-19 vaccine
COVID19 | News | 0 Comment | 27 Apr, 2020
China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...Read more